• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

We're Changing Our Strategy on AstraZeneca

Even today's earnings beat is not 'moving the needle' enough.
By BRUCE KAMICH
Feb 10, 2022 | 12:58 PM EST
Stocks quotes in this article: AZN

AstraZeneca (AZN) reported better than expected EPS and revenue numbers this Thursday morning, but the price action may need a change of strategy. In our December 23 review of the charts and indicators of AZN we wrote that "Broadening patterns can be tricky to trade as they oscillate in a wider and wider pattern when we are more used to seeing patterns get tighter and tighter - like winding up a watch spring. Traders could go long AZN at current levels risking to $53. On the upside we look for new highs well above $64." 

 
Prices did improve in January and stayed above our stop out point but the advance has not been as strong as anticipated. Even today's earnings beat is not "moving the needle" enough so we need to pivot in another direction. 
 
In this daily bar chart of AZN, below, we can see that prices stalled at $60 just around the bottom of the price gap in November. With prices stopping at this point in the broadening pattern we discussed in December, the pattern is morphing into something else.
 
Prices are back above the popular moving averages that we follow but the On-Balance-Volume (OBV) line has weakened since the middle of January telling me that sellers of AZN are being more aggressive.
 
The Moving Average Convergence Divergence (MACD) oscillator is hugging the zero line.  
 
 
In this weekly Japanese candlestick chart of AZN, below, we can see a mixed picture. Prices are showing two upper shadows around $60 and AZN is trading around the 40-week line. The OBV line improved slightly in December and January but it is not leading the way with a new high. The MACD oscillator is close to the zero line and not showing us what we want to see. 
 
 
 
In this daily Point and Figure chart of AZN, below, we can see that the software is now generating a downside price target in the $44 area. 
 
 
 
In this weekly Point and Figure chart of AZN, below, we can see the same downside price target of $44. 
 
 
 
Bottom line strategy: We could just recommend staying long AZN and tighten the stop but when the charts and indicators change it is wise not to ignore their message. Traders long AZN should take profits here and look for new opportunities elsewhere. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Earnings | Investing | Stocks | Technical Analysis | Trading | Pharmaceuticals

More from Investing

How To Adjust Your Trading Style as Market Conditions Change

James "Rev Shark" DePorre
Mar 25, 2023 10:00 AM EDT

There is no single approach to the stock market that is inherently superior over the long run.

The Chasing Slows on Wall Street

James "Rev Shark" DePorre
Mar 24, 2023 4:34 PM EDT

After Deutsche Bank shakes up investors, market cools a bit, which might be a healthy development.

Stay Away From These Types of Stocks, They're Radioactive

Jim Collins
Mar 24, 2023 2:35 PM EDT

Here's what you're better off buying. I certainly have.

GE Looks Poised for a Pullback: How to Trade It Now

Bruce Kamich
Mar 24, 2023 1:45 PM EDT

The shares stopped short of my price targets.

See SPOT Run ... Down

Bruce Kamich
Mar 24, 2023 1:23 PM EDT

Spotify looks like it is poised for a downside price correction, according to the charts.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • 08:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How to Adjust Your Trading Style as Market Conditi...
  • 05:00 PM EDT CHRIS VERSACE

    AAP Podcast on the Fed Decision!

    Listen here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login